{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:24Z","timestamp":1792664664793,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.det.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T06:22:39Z","timestamp":1622442159000},"page":"487-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Patterns and Morphology of COVID-19 Dermatology"],"prefix":"10.1016","volume":"39","author":[{"given":"Ritesh","family":"Agnihothri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.det.2021.05.006_bib1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3748\/wjg.v26.i14.1546","article-title":"SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant","volume":"26","author":"Hajifathalian","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"23","key":"10.1016\/j.det.2021.05.006_bib2","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic Features in Severe SARS-CoV-2 Infection","volume":"382","author":"Helms","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.det.2021.05.006_bib3","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: Emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib5","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1111\/jdv.16470","article-title":"Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies","volume":"34","author":"Fernandez-Nieto","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"18","key":"10.1016\/j.det.2021.05.006_bib6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib7","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/jdv.16387","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib8","first-page":"302","article-title":"Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41584-020-0418-0","article-title":"The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic","volume":"16","author":"Robinson","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaad.2020.04.045","article-title":"The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib12","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.jaad.2020.06.050","article-title":"International collaboration and rapid harmonization across dermatologic COVID-19 registries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib14","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jid.2020.05.087","article-title":"High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2","volume":"141","author":"Xue","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2021.05.006_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-008-0942-9","article-title":"Chilblain lupus erythematosus - A review of literature","volume":"27","author":"Hedrich","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mayocp.2013.09.020","article-title":"Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011","volume":"89","author":"Cappel","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib19","first-page":"71","article-title":"Acute Acro-ischemia in the Child at the time of COVID-19","volume":"30","author":"Mazzotta","year":"2020","journal-title":"Eur J Pediat Dermatol"},{"issue":"8","key":"10.1016\/j.det.2021.05.006_bib20","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1111\/jdv.16572","article-title":"The use of Google Trends for acral symptoms during COVID-19 outbreak in France","volume":"34","author":"Kluger","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/bjd.19243","article-title":"Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection","volume":"183","author":"Hughes","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2020.05.145","article-title":"Chilblain-like acral lesions during the COVID-19 pandemic (\u201cCOVID toes\u201d): Histologic, immunofluorescence, and immunohistochemical study of 17 cases","volume":"83","author":"Kanitakis","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France","volume":"83","author":"de Masson","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19894","article-title":"Cold and COVID: recurrent pernio during the COVID-19 pandemic","author":"Freeman","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib25","article-title":"Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients with Chilblain-like Lesions during the COVID-19 Pandemic","author":"Hubiche","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14089","article-title":"Auricle perniosis as a manifestation of Covid-19 infection","volume":"33","author":"Proietti","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2021.05.006_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19377","article-title":"Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on PCR and serology testing","author":"Le Cleach","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19\u2013associated dermatologic manifestations: An international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib29","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jaad.2020.04.093","article-title":"Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/pde.14215","article-title":"Chilblains in children in the setting of COVID-19 pandemic","volume":"37","author":"Andina","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jdcr.2020.04.011","article-title":"Coronavirus (COVID-19) infection\u2013induced chilblains: A case report with histopathologic findings","volume":"6","author":"Kolivras","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib33","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/jth.15008","article-title":"Are chilblains a skin expression of COVID-19 microangiopathy?","volume":"18","author":"Baeck","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.det.2021.05.006_bib34","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1111\/jdv.16800","article-title":"Dermoscopy features of COVID-19-related chilblains in children and adolescents","volume":"34","author":"Navarro","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib35","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jaad.2020.07.058","article-title":"Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients","volume":"83","author":"Piccolo","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.01.023","article-title":"The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients","author":"Marzano","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30986-5","article-title":"Long COVID in the skin: a registry analysis of COVID-19 dermatological duration","author":"McMahon","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/bmb\/ldn049","article-title":"Aicardi-Goutires syndrome","volume":"89","author":"Orcesi","year":"2009","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.19338","article-title":"COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient","volume":"183","author":"Santonja","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib41","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1111\/jdv.16970","article-title":"SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion","volume":"35","author":"Gambichler","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2021.05.006_bib42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/cup.13830","article-title":"Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2","volume":"47","author":"Ko","year":"2020","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib43","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/bjd.19489","article-title":"Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned","volume":"183","author":"Baeck","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bjd.19572","article-title":"SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions","volume":"184","author":"Brealey","year":"2021","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib45","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1111\/jdv.16544","article-title":"Vascular skin symptoms in COVID-19: a French observational study","volume":"34","author":"Bouaziz","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.det.2021.05.006_bib46","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon\u00e2-mediated monogenic autoinflammation: The type i interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib47","first-page":"590","article-title":"Monogenetic causes of chilblains, panniculitis and vasculopathy: The Type I interferonopathies","volume":"155","author":"Papa","year":"2020","journal-title":"G\u00a0Ital di Dermatologia e Venereol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/dermatopathology7030010","article-title":"Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic","volume":"7","author":"Aschoff","year":"2020","journal-title":"Dermatopathology"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-016-0961-7","article-title":"Lupus pathobiology based on genomics","volume":"69","author":"Saeed","year":"2017","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type i interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib51","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/jdv.16669","article-title":"Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19","volume":"34","author":"Guarneri","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib52","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1111\/jdv.16901","article-title":"Chilblains and COVID-19: further evidence against a causal association","volume":"35","author":"Baeck","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaad.2020.06.019","article-title":"Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic","volume":"83","author":"Colonna","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib54","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jaad.2020.08.021","article-title":"All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions","volume":"83","author":"Denina","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2021.05.006_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16682","article-title":"A\u00a0clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection","volume":"34","author":"El Hachem","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13516","article-title":"Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak","volume":"33","author":"Garcia-Lara","year":"2020","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib58","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jaad.2020.08.049","article-title":"Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic","volume":"83","author":"Stavert","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib59","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamadermatol.2020.2340","article-title":"Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents during the COVID-19 Pandemic","volume":"156","author":"Roca-Gin\u00e9s","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib60","article-title":"Negative SARS-CoV-2 PCR in patients with chilblain-like lesions","author":"Hubiche","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib61","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40122-020-00174-4","article-title":"Images in Practice: Painful Cutaneous Vasculitis in a SARS-Cov-2 IgG-Positive Child","volume":"9","author":"Papa","year":"2020","journal-title":"Pain Ther"},{"issue":"22","key":"10.1016\/j.det.2021.05.006_bib62","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting Diagnostic Tests for SARS-CoV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaad.2020.09.007","article-title":"Timing of PCR and antibody testing in patients with COVID-19\u2013associated dermatologic manifestations","volume":"84","author":"Freeman","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"7821","key":"10.1016\/j.det.2021.05.006_bib65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib66","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"577","key":"10.1016\/j.det.2021.05.006_bib67","first-page":"13","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.det.2021.05.006_bib68","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fimmu.2020.00902","article-title":"IgA Responses Following Recurrent Influenza Virus Vaccination","volume":"11","author":"Abreu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.det.2021.05.006_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2020.10.021","article-title":"COVID toes: Where do we stand with the current evidence?","volume":"102","author":"Baeck","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"6504","key":"10.1016\/j.det.2021.05.006_bib70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"7834","key":"10.1016\/j.det.2021.05.006_bib71","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/d41586-020-03070-1","article-title":"Interferon deficiency can lead to severe COVID","volume":"587","author":"Meffre","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.19415","article-title":"The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series","volume":"184","author":"Magro","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib73","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and Type III Interferons \u2013 Induction, Signaling, Evasion, and Application to Combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.det.2021.05.006_bib74","doi-asserted-by":"crossref","first-page":"109959","DOI":"10.1016\/j.mehy.2020.109959","article-title":"A\u00a0chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?","volume":"144","author":"Lipsker","year":"2020","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib75","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2020.06.1018","article-title":"New insights in COVID-19\u2013associated chilblains: A comparative study with chilblain lupus erythematosus","volume":"83","author":"Battesti","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib76","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.jaad.2020.06.052","article-title":"When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection","volume":"83","author":"Damsky","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2021.05.006_bib77","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1111\/jdv.16733","article-title":"Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology","volume":"34","author":"Rodr\u00edguez-Villa Lario","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib78","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jdcr.2020.04.015","article-title":"Morbilliform exanthem associated with COVID-19","volume":"6","author":"Najarian","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"10","key":"10.1016\/j.det.2021.05.006_bib81","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1111\/jdv.16734","article-title":"The broad spectrum of dermatological manifestations in COVID-19: clinical and histopathological features learned from a series of 34 cases","volume":"34","author":"Rubio-Muniz","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2021.05.006_bib82","doi-asserted-by":"crossref","first-page":"634208","DOI":"10.3389\/fmed.2021.634208","article-title":"Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review","volume":"8","author":"Jamshidi","year":"2021","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.det.2021.05.006_bib83","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1111\/jdv.16707","article-title":"Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients","volume":"34","author":"Reymundo","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13476","article-title":"Cutaneous s\u0131de-effects of the potential COVID-19 drugs","volume":"33","author":"T\u00fcrsen","year":"2020","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236981","article-title":"Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection","volume":"13","author":"Hassan","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib86","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1111\/jdv.16523","article-title":"Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection","volume":"34","author":"van Damme","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib87","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jdcr.2020.04.026","article-title":"Urticarial exanthem as early diagnostic clue for COVID-19 infection","volume":"6","author":"Quintana-Castanedo","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2500\/aap.2016.37.3915","article-title":"Association between urticaria and virus infections: A systematic review","volume":"37","author":"Imbalzano","year":"2016","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib89","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/fmb-2016-0147","article-title":"Contemporary infectious exanthems: An update","volume":"12","author":"Drago","year":"2017","journal-title":"Future Microbiol"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2020.04.044","article-title":"Varicella-like exanthem as a specific COVID-19\u2013associated skin manifestation: Multicenter case series of 22 patients","volume":"83","author":"Marzano","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib91","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ced.14277","article-title":"Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital","volume":"45","author":"Fernandez-Nieto","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.det.2021.05.006_bib92","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1111\/jdv.16706","article-title":"Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not \u2018varicella-like","volume":"34","author":"Mah\u00e9","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.det.2021.05.006_bib93","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamadermatol.2020.1966","article-title":"Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient with COVID-19","volume":"156","author":"Trellu","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib94","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/ced.14281","article-title":"Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings","volume":"45","author":"Jimenez-Cauhe","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13779","article-title":"A\u00a0fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever","volume":"33","author":"Gargiulo","year":"2020","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib96","doi-asserted-by":"crossref","first-page":"e236986","DOI":"10.1136\/bcr-2020-236986","article-title":"Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: Erythema multiforme","volume":"13","author":"Bapst","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.det.2021.05.006_bib97","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/jdv.16623","article-title":"Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2","volume":"34","author":"Janah","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib98","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jaad.2020.05.073","article-title":"Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy","volume":"83","author":"De Giorgi","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib99","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/pde.14246","article-title":"Erythema multiforme-like lesions in children and COVID-19","volume":"37","author":"Torrelo","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib100","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1111\/jdv.16618","article-title":"Urticaria-like lesions in COVID-19 patients are not really urticaria \u2013 a case with clinicopathological correlation","volume":"34","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14096","article-title":"Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID-19 pandemic","volume":"33","author":"Kutlu","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2021.05.006_bib102","article-title":"Pityriasis rosea as a leading manifestation of COVID-19 infection","author":"Merhy","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib103","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1111\/jdv.16579","article-title":"Pityriasis rosea as a cutaneous manifestation of COVID-19 infection","volume":"34","author":"Ehsani","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13730","article-title":"The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease","volume":"33","author":"Dursun","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2021.05.006_bib105","article-title":"Pityriasis rosea and COVID-19","author":"Veraldi","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.det.2021.05.006_bib106","article-title":"Pityriasis rosea-like eruption revealing COVID-19","author":"Veraldi","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.medcle.2020.05.017","article-title":"Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19","volume":"155","author":"Mart\u00edn Enguix","year":"2020","journal-title":"Med Cl\u00ednica (English Ed"},{"issue":"7","key":"10.1016\/j.det.2021.05.006_bib108","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2020.1704","article-title":"Digitate Papulosquamous Eruption Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"156","author":"Sanchez","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib109","article-title":"Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19","author":"Drago","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.det.2021.05.006_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19833","article-title":"SARS-CoV-2 Spike Protein Positivity in Pityriasis Rosea-like and Urticaria-like Rashes of COVID-19","author":"Welsh","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib112","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/j.bja.2020.05.026","article-title":"Presenting symptoms of COVID-19 in children: a meta-analysis of published studies","volume":"125","author":"Assaker","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.det.2021.05.006_bib113","article-title":"Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections","author":"Zimmermann","year":"2020","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/20469047.2020.1804733","article-title":"Clinical and laboratory characteristics of SARS-CoV2-infected paediatric patients in Jordan: serial RT-PCR testing until discharge","volume":"41","author":"Kilani","year":"2021","journal-title":"Paediatr Int Child Health"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jped.2020.08.007","article-title":"Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations","volume":"97","author":"Pousa","year":"2021","journal-title":"J\u00a0Pediatr (Rio J"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib116","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaad.2020.10.060","article-title":"Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children","volume":"84","author":"Rekhtman","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2021.05.006_bib117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.det.2021.05.006_bib118","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.det.2021.05.006_bib119","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA - J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib122","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ppul.25245","article-title":"COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis","volume":"56","author":"Yasuhara","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.det.2021.05.006_bib123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.037","article-title":"Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses","volume":"227","author":"Yonker","year":"2020","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib124","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10787-020-00739-x","article-title":"A\u00a0viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms","volume":"28","author":"Roe","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"18","key":"10.1016\/j.det.2021.05.006_bib125","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMc2026136","article-title":"Multisystem Inflammatory Syndrome in Children in the United States","volume":"383","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2021.05.006_bib126","article-title":"Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic","author":"Young","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib127","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"issue":"10246","key":"10.1016\/j.det.2021.05.006_bib128","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S0140-6736(20)31526-9","article-title":"An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19","volume":"396","author":"Shaigany","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.det.2021.05.006_bib129","author":"Morris"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem Inflammatory Syndrome in U.S. Children and Adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2021.05.006_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: A systematic review","volume":"26","author":"Ahmed","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib132","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jaad.2020.03.036","article-title":"COVID-19 can present with a rash and be mistaken for dengue","volume":"82","author":"Joob","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib133","series-title":"Petechiae. In: StatPearls [Internet]","author":"McGrath","year":"2021"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib134","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13896","article-title":"Cutaneous manifestations in hospitalized patients diagnosed as COVID-19","volume":"33","author":"Askin","year":"2020","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.det.2021.05.006_bib135","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13798","article-title":"A\u00a0unilateral purpuric rash in a patient with COVID-19 infection","volume":"33","author":"Karaca","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2021.05.006_bib136","doi-asserted-by":"crossref","first-page":"e20200464","DOI":"10.1590\/0037-8682-0464-2020","article-title":"Purpuric rash on the legs of a patient with coronavirus disease","volume":"53","author":"Silva","year":"2020","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"10.1016\/j.det.2021.05.006_bib137","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1111\/jdv.16760","article-title":"An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient","volume":"34","author":"Negrini","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2021.05.006_bib138","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ekir.2020.08.016","article-title":"IgA Vasculitis With Nephritis (Henoch\u2212Sch\u00f6nlein Purpura) in a COVID-19 Patient","volume":"5","author":"Suso","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.det.2021.05.006_bib139","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239910","article-title":"A\u00a0child with Henoch-Schonlein purpura secondary to a COVID-19 infection","volume":"14","author":"AlGhoozi","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib140","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/INF.0000000000003001","article-title":"Purpurona: A Novel Report of COVID-19-Related Henoch-Schonlein Purpura in a Child","volume":"40","author":"Jacobi","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.det.2021.05.006_bib141","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/ijd.15233","article-title":"Livedo reticularis and acrocyanosis as late manifestations of COVID-19 in two cases with familial aggregation. Potential pathogenic role of complement (C4c)","volume":"59","author":"Garc\u00eda-Gil","year":"2020","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.006_bib142","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jdcr.2020.07.014","article-title":"Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection","volume":"6","author":"Khalil","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.det.2021.05.006_bib143","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2020.04.018","article-title":"A\u00a0dermatologic manifestation of COVID-19: Transient livedo reticularis","volume":"83","author":"Manalo","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"issue":"10","key":"10.1016\/j.det.2021.05.006_bib145","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1111\/jdv.16689","article-title":"Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy","volume":"34","author":"Bosch-Amate","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2021.05.006_bib146","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdcr.2021.01.019","article-title":"Purpuric ulcers associated with COVID-19: A case series","volume":"11","author":"Chand","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2021.05.006_bib147","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdin.2020.12.003","article-title":"Skin manifestations of COVID-19: A worldwide review","volume":"2","author":"Tan","year":"2021","journal-title":"JAAD Int"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib148","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/j.jaad.2020.07.099","article-title":"Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign","volume":"83","author":"Wambier","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib149","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.jaad.2020.09.015","article-title":"Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals","volume":"83","author":"Wambier","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib150","first-page":"e14761","article-title":"Telogen effluvium associated with <scp>COVID<\/scp> -19 infection","author":"Olds","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2021.05.006_bib151","doi-asserted-by":"crossref","DOI":"10.31128\/AJGP-COVID-32","article-title":"Acute telogen effluvium associated with SARS-CoV-2 infection","volume":"49","author":"Dom\u00ednguez-Sant\u00e1s","year":"2020","journal-title":"Aust J Gen Pract"},{"issue":"16","key":"10.1016\/j.det.2021.05.006_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/00015555-3641","article-title":"An isolated peculiar gianotti-crosti rash in the course of a covid-19 episode","volume":"100","author":"Brin","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2021.05.006_bib153","article-title":"SDRIFE-like rash associated with COVID-19, clinicopathological correlation","author":"Chicharro","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib154","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1111\/jdv.16471","article-title":"A\u00a0distinctive skin rash associated with coronavirus disease 2019?","volume":"34","author":"Mah\u00e9","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2021.05.006_bib155","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ijd.15104","article-title":"Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient","volume":"59","author":"Boix-Vilanova","year":"2020","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib156","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14170","article-title":"Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study","volume":"33","author":"Catal\u00e0","year":"2020","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib157","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2021.0385","article-title":"Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection","volume":"157","author":"Holcomb","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.det.2021.05.006_bib158","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jamadermatol.2020.2550","article-title":"Enanthem in Patients with COVID-19 and Skin Rash","volume":"156","author":"Jimenez-Cauhe","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2021.05.006_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2226","article-title":"Covid-19 and oral diseases: Crosstalk, synergy or association?","author":"Brandini","year":"2021","journal-title":"Rev Med Virol Published Online"},{"key":"10.1016\/j.det.2021.05.006_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.571214","article-title":"Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection","volume":"7","author":"La Rosa","year":"2021","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.det.2021.05.006_bib161","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1111\/jdv.16740","article-title":"COVID-19-related acute genital ulcers","volume":"34","author":"Falkenhain-L\u00f3pez","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib162","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/INF.0000000000002700","article-title":"COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.det.2021.05.006_bib163","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/23744235.2020.1747634","article-title":"Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report","volume":"52","author":"Kamali Aghdam","year":"2020","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.det.2021.05.006_bib164","article-title":"Emerging Evidence of the Direct Association Between COVID-19 and Chilblains","author":"Freeman","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.05.006_bib165","first-page":"184","article-title":"Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection","author":"Visconti","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.006_bib166","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/bjd.19258","article-title":"Absence of images of skin of colour in publications of COVID-19 skin manifestations","volume":"183","author":"Lester","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:06:51Z","timestamp":1718762811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863521000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":163,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0733863521000437"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2021.05.006","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Patterns and Morphology of COVID-19 Dermatology","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}